Dr. Hao got his medical degree from Inner Mongolia Medical College in Northern China. He subsequently pursued his passion in research and earned a PhD in molecular biology and biochemistry in the University of Tokyo. Following a productive postdoctoral period in the University of Virginia, he trained in internal medicine in Mercer University School of Medicine and in Hematology and Oncology in Emory’s Winship Cancer Institute. He is currently leader of thoracic medical oncology program in Markey Cancer Center, Professor of Medicine and Cancer Biology at the University of Kentucky’s Markey Cancer Center. He is also medical director of the Markey Clinical Research Organization and the founding medical director of Markey’s Multisite Research Operations and Donna and William Shively Endowed Professor in Clinical Translational Oncology. His research interests include molecularly targeted therapy and immunotherapy in lung cancer. He coauthored ~ 60 peer reviewed scientific papers and is PI of multiple Investigator Initiated Clinical Trials and PI of the first in human CART cell and Tri-specific engager in small cell lung cancer.